Cargando…

Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy

OBJECTIVE: Nomograms are statistics-based predictive tools that integrate predictive factors. Herein, a nomogram was developed and validated to predict the overall survival (OS) in serous ovarian cancer (SOC). METHODS: Primary SOC patients with satisfactory cytoreductive surgery, chemotherapy, and O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yuan-Yuan, Zhao, Ren-Feng, Liu, Chao, Zhou, Jie, Yang, Liu, Li, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747526/ https://www.ncbi.nlm.nih.gov/pubmed/35023951 http://dx.doi.org/10.2147/IJGM.S337827

Ejemplares similares

Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
por: Li, Jun, et al.
Publicado: (2019)

Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery
por: Ma, Guanchen, et al.
Publicado: (2023)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
por: Kim, Se Ik, et al.
Publicado: (2022)

Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
por: Chokshi, Ravi J., et al.
Publicado: (2020)

Clinical Nomograms for Predicting the Overall Survival and Cancer-specific Survival of patients with Ovarian Carcinosarcoma patients after Primary Surgery
por: Ren, Fang, et al.
Publicado: (2021)

Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma
por: Liu, Qinglin, et al.
Publicado: (2020)

Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database
por: Huang, Wu, et al.
Publicado: (2022)

Severe pulmonary complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are common and contribute to decreased overall survival
por: Sand, Olivia, et al.
Publicado: (2021)

Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
por: Zhang, Jue, et al.
Publicado: (2021)

Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2020)

Construction and validation of a novel aging‐related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer
por: Liu, Lixiao, et al.
Publicado: (2021)

Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma
por: Yuan, Dandan, et al.
Publicado: (2023)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
por: Jernigan, Amelia M., et al.
Publicado: (2013)

Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience
por: Cheng, Ernest, et al.
Publicado: (2023)

Race and Ethnicity Impacts Overall Survival of Patients with Appendiceal Cancer Who Undergo Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Freudenberger, Devon C., et al.
Publicado: (2023)

Development and Validation a Nomogram for Predicting Overall Survival in Patients With Intrahepatic Cholangiocarcinoma
por: Yuan, Chen, et al.
Publicado: (2021)

The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction
por: Johnson, Racheal Louise, et al.
Publicado: (2021)

Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review
por: Chase, Dana M, et al.
Publicado: (2023)

A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy
por: Zeng, Yuan, et al.
Publicado: (2021)

New nomograms to predict overall and cancer‐specific survival of angiosarcoma
por: Liu, Yuan‐Yuan, et al.
Publicado: (2021)

Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
por: Chen, Qian, et al.
Publicado: (2020)

Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study
por: Jiang, Caixia, et al.
Publicado: (2022)

Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
por: Shin, Wonkyo, et al.
Publicado: (2020)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan
por: Hsieh, Mao-Chih, et al.
Publicado: (2017)

The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020)

Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer
por: Diao, Jian‐dong, et al.
Publicado: (2019)

Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
por: Lin, Wei-Xun, et al.
Publicado: (2022)

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
por: Bogani, Giorgio, et al.
Publicado: (2018)

Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer
por: Li, Qiaqia, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018)

Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer
por: Cheng, Hao, et al.
Publicado: (2023)

Fatal cardiac tamponade following cytoreductive surgery for serous carcinoma of the ovary
por: English, Emily, et al.
Publicado: (2015)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms
por: Zhang, Sheng, et al.
Publicado: (2019)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
por: Zhang, Guyu, et al.
Publicado: (2019)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

A web-based nomogram to predict overall survival for postresection leiomyosarcoma patients with lung metastasis
por: Wei, Junqiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_inpahnb6m6e9foi2p84jhpis9r